Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.

Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M.

Lancet Oncol. 2019 May 28. pii: S1470-2045(19)30277-3. doi: 10.1016/S1470-2045(19)30277-3. [Epub ahead of print]

PMID:
31151904
2.

Concurrent Spinal Epidural Tubercular and Pyogenic Abscess of Cervical Spine without Bony Involvement.

Diyora B, Patil S, Bhende B, Patel M, Dhall G, Nayak N.

J Neurosci Rural Pract. 2019 Apr-Jun;10(2):374-378. doi: 10.4103/jnrp.jnrp_318_18.

3.

Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus Carcinoma.

Wang J, Merino DM, Light N, Murphy BL, Wang YD, Guo X, Hodges AP, Chau LQ, Liu KW, Dhall G, Asgharzadeh S, Kiehna EN, Shirey RJ, Janda KD, Taylor MD, Malkin D, Ellison DW, VandenBerg SR, Eberhart CG, Sears RC, Roussel MF, Gilbertson RJ, Wechsler-Reya RJ.

Cancer Res. 2019 May 1;79(9):2208-2219. doi: 10.1158/0008-5472.CAN-18-2565. Epub 2019 Mar 18.

PMID:
30885981
4.

Subcutaneous Cerebrospinal Fluid Pseudocyst: An Unusual Complication of Ventriculoperitoneal Shunt.

Diyora B, Bhende B, Dhall G, Kamble H, Nayak N.

J Neurosci Rural Pract. 2019 Jan-Mar;10(1):164-165. doi: 10.4103/jnrp.jnrp_142_18. No abstract available.

5.

Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.

Toll SA, Tran HN, Cotter J, Judkins AR, Tamrazi B, Biegel JA, Dhall G, Robison NJ, Waters K, Patel P, Cooper R, Margol AS.

Oncotarget. 2019 Jan 11;10(4):551-557. doi: 10.18632/oncotarget.26560. eCollection 2019 Jan 11.

6.

Ventral Craniovertebral Junction Arachnoid Cyst in an Elderly Patient-A Case Report of a Unique Occurrence at Extremes of Age.

Diyora B, Bhende B, Dhall G, Patil A, Nayak N.

World Neurosurg. 2019 Feb;122:577-582. doi: 10.1016/j.wneu.2018.11.107. Epub 2018 Nov 22. Review.

PMID:
30472283
7.

A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children's Oncology Group.

Margol AS, Yeo KK, Xia C, Onar A, Robison NJ, Freyer DR, Dhall G.

J Neurooncol. 2018 Dec;140(3):575-582. doi: 10.1007/s11060-018-2983-5. Epub 2018 Sep 1.

PMID:
30173409
8.

Brain Irradiation and Gadobutrol Administration in Pediatric Patients with Brain Tumors: Effect on MRI Brain Signal Intensity.

Tamrazi B, Liu CJ, Cen SY, Nelson MB, Dhall G, Nelson MD.

Radiology. 2018 Oct;289(1):188-194. doi: 10.1148/radiol.2018173057. Epub 2018 Jul 10.

PMID:
29989524
9.

A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system.

Manley PE, Trippett T, Smith AA, Macy ME, Leary SES, Boklan J, Cohen KJ, Goldman S, Kilburn LB, Dhall G, Devin J, Herzog CE, Partap S, Fauchet F, Badreddine E, Bernard JP, Chi SN.

Pediatr Blood Cancer. 2018 Sep;65(9):e27217. doi: 10.1002/pbc.27217. Epub 2018 May 11.

PMID:
29750396
10.

Transmission of a TP53 germline mutation from unaffected male carrier associated with pediatric glioblastoma in his child and gestational choriocarcinoma in his female partner.

Cotter JA, Szymanski L, Karimov C, Boghossian L, Margol A, Dhall G, Tamrazi B, Varaprasathan GI, Parham DM, Judkins AR, Biegel JA.

Cold Spring Harb Mol Case Stud. 2018 Apr 2;4(2). pii: a002576. doi: 10.1101/mcs.a002576. Print 2018 Apr. Review.

11.

Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.

Robison NJ, Yeo KK, Berliner AP, Malvar J, Sheard MA, Margol AS, Seeger RC, Rushing T, Finlay JL, Sposto R, Dhall G.

J Neurooncol. 2018 May;138(1):199-207. doi: 10.1007/s11060-018-2791-y. Epub 2018 Feb 9.

12.

Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy.

Paret C, Russo A, Otto H, Mayer A, Zahnreich S, Wagner W, Samuel D, Scharnhorst D, Solomon DA, Dhall G, Wong K, Bender H, Alt F, Wingerter A, Neu MA, Beck O, Prawitt D, Eder S, Henninger N, El Malki K, Lehmann N, Backes N, Roth L, Seidmann L, Sommer C, Brockmann MA, Staatz G, Schmidberger H, Faber J.

Oncotarget. 2017 Dec 11;8(69):114210-114225. doi: 10.18632/oncotarget.23174. eCollection 2017 Dec 26.

13.

Long-term evidence that a pediatric oncology mentorship program for young investigators is feasible and beneficial in the cooperative group setting: A report from the Children's Oncology Group.

Esbenshade AJ, Pierson CR, Thompson AL, Reed D, Gupta A, Levy A, Kahalley LS, Harker-Murray P, Schore R, Muscal JA, Embry L, Maloney K, Horton T, Zweidler-Mckay P, Dhall G.

Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26878. Epub 2017 Nov 28.

PMID:
29193588
14.
15.

Marrow-ablative chemotherapy followed by tandem autologous hematopoietic cell transplantation in pediatric patients with malignant brain tumors.

Guerra JA, Dhall G, Marachelian A, Castillo E, Malvar J, Wong K, Sposto R, Finlay JL.

Bone Marrow Transplant. 2017 Nov;52(11):1543-1548. doi: 10.1038/bmt.2017.166. Epub 2017 Aug 7.

PMID:
28783147
16.

Long-term follow-up of endocrine function among young children with newly diagnosed malignant central nervous system tumors treated with irradiation-avoiding regimens.

Cochrane AM, Cheung C, Rangan K, Freyer D, Nahata L, Dhall G, Finlay JL.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26616. Epub 2017 May 5.

PMID:
28475292
17.

Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach.

Fay-McClymont TB, Ploetz DM, Mabbott D, Walsh K, Smith A, Chi SN, Wells E, Madden J, Margol A, Finlay J, Kieran MW, Strother D, Dhall G, Packer RJ, Foreman NK, Bouffet E, Lafay-Cousin L.

J Neurooncol. 2017 May;133(1):119-128. doi: 10.1007/s11060-017-2409-9. Epub 2017 Apr 12.

PMID:
28405869
18.

Radiotherapy after high-dose chemotherapy with autologous hematopoietic cell rescue: Quality assessment of Head Start III.

Wong KK, All S, Waxer J, Olch AJ, Venkatramani R, Dhall G, Davidson TB, Zaky W, Finlay JL.

Pediatr Blood Cancer. 2017 Oct;64(10). doi: 10.1002/pbc.26529. Epub 2017 Apr 5.

PMID:
28379644
19.

Vincristine and Vinblastine: Is checking bilirubin mandatory in children with Brain Tumors?

Madden JR, Evans A, Hemenway M, Stark E, Kissell E, Polito A, Batson D, Stark M, Dhall G, Garvin JH, Foreman NK, Vibhakar R.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26329. Epub 2016 Nov 3. No abstract available.

PMID:
27808466
20.

False-positive magnetic resonance imaging findings in follow-up of pediatric patients with tumors of the central nervous system.

De Oliveira SN, Gonzalez-Gomez I, Panigrahy A, Krieger M, McComb G, Finlay JL, Dhall G.

SAGE Open Med Case Rep. 2016 Aug 26;4:2050313X16666232. doi: 10.1177/2050313X16666232. eCollection 2016.

21.

A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study.

Salloum R, Hummel TR, Kumar SS, Dorris K, Li S, Lin T, Daryani VM, Stewart CF, Miles L, Poussaint TY, Stevenson C, Goldman S, Dhall G, Packer R, Fisher P, Pollack IF, Fouladi M, Boyett J, Drissi R.

J Neurooncol. 2016 Sep;129(3):443-451. doi: 10.1007/s11060-016-2189-7. Epub 2016 Jun 27.

22.

Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials.

Espinoza JC, Haley K, Patel N, Dhall G, Gardner S, Allen J, Torkildson J, Cornelius A, Rassekh R, Bedros A, Etzl M, Garvin J, Pradhan K, Corbett R, Sullivan M, McGowage G, Stein D, Jasty R, Sands SA, Ji L, Sposto R, Finlay JL.

Pediatr Blood Cancer. 2016 Oct;63(10):1806-13. doi: 10.1002/pbc.26118. Epub 2016 Jun 22.

23.

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.

Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, Jones DT, Luu B, Cavalli FM, Aldape K, Remke M, Mynarek M, Rutkowski S, Gururangan S, McLendon RE, Lipp ES, Dunham C, Hukin J, Eisenstat DD, Fulton D, van Landeghem FK, Santi M, van Veelen ML, Van Meir EG, Osuka S, Fan X, Muraszko KM, Tirapelli DP, Oba-Shinjo SM, Marie SK, Carlotti CG, Lee JY, Rao AA, Giannini C, Faria CC, Nunes S, Mora J, Hamilton RL, Hauser P, Jabado N, Petrecca K, Jung S, Massimi L, Zollo M, Cinalli G, Bognár L, Klekner A, Hortobágyi T, Leary S, Ermoian RP, Olson JM, Leonard JR, Gardner C, Grajkowska WA, Chambless LB, Cain J, Eberhart CG, Ahsan S, Massimino M, Giangaspero F, Buttarelli FR, Packer RJ, Emery L, Yong WH, Soto H, Liau LM, Everson R, Grossbach A, Shalaby T, Grotzer M, Karajannis MA, Zagzag D, Wheeler H, von Hoff K, Alonso MM, Tuñon T, Schüller U, Zitterbart K, Sterba J, Chan JA, Guzman M, Elbabaa SK, Colman H, Dhall G, Fisher PG, Fouladi M, Gajjar A, Goldman S, Hwang E, Kool M, Ladha H, Vera-Bolanos E, Wani K, Lieberman F, Mikkelsen T, Omuro AM, Pollack IF, Prados M, Robins HI, Soffietti R, Wu J, Metellus P, Tabori U, Bartels U, Bouffet E, Hawkins CE, Rutka JT, Dirks P, Pfister SM, Merchant TE, Gilbert MR, Armstrong TS, Korshunov A, Ellison DW, Taylor MD.

J Clin Oncol. 2016 Jul 20;34(21):2468-77. doi: 10.1200/JCO.2015.65.7825. Epub 2016 Jun 6.

24.

Re-irradiation of Recurrent Pineal Germ Cell Tumors with Radiosurgery: Report of Two Cases and Review of Literature.

Wong K, Opimo AB, Olch AJ, All S, Waxer JF, Clark D, Cheng J, Chlebik A, Erdreich-Epstein A, Krieger MD, Tamrazi B, Dhall G, Finlay JL, Chang EL.

Cureus. 2016 Apr 25;8(4):e585. doi: 10.7759/cureus.585. Review.

25.

Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy.

Lafay-Cousin L, Smith A, Chi SN, Wells E, Madden J, Margol A, Ramaswamy V, Finlay J, Taylor MD, Dhall G, Strother D, Kieran MW, Foreman NK, Packer RJ, Bouffet E.

Pediatr Blood Cancer. 2016 Sep;63(9):1527-34. doi: 10.1002/pbc.26042. Epub 2016 May 4. Erratum in: Pediatr Blood Cancer. 2017 Apr;64(4):.

26.

Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study.

Lulla RR, Goldman S, Yamada T, Beattie CW, Bressler L, Pacini M, Pollack IF, Fisher PG, Packer RJ, Dunkel IJ, Dhall G, Wu S, Onar A, Boyett JM, Fouladi M.

Neuro Oncol. 2016 Sep;18(9):1319-25. doi: 10.1093/neuonc/now047. Epub 2016 Mar 28.

27.

Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the 'Head Start' trials, 1991-2009.

Altshuler C, Haley K, Dhall G, Vasquez L, Gardner SL, Stanek J, Finlay JL.

Bone Marrow Transplant. 2016 Jul;51(7):945-8. doi: 10.1038/bmt.2016.45. Epub 2016 Mar 7.

PMID:
26950375
28.

Effect of Sensorineural Hearing Loss on Neurocognitive Functioning in Pediatric Brain Tumor Survivors.

Orgel E, O'Neil SH, Kayser K, Smith B, Softley TL, Sherman-Bien S, Counts PA, Murphy D, Dhall G, Freyer DR.

Pediatr Blood Cancer. 2016 Mar;63(3):527-34. doi: 10.1002/pbc.25804. Epub 2015 Nov 3.

29.

Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report.

Ko RH, Jones TL, Radvinsky D, Robison N, Gaynon PS, Panosyan EH, Avramis IA, Avramis VI, Rubin J, Ettinger LJ, Seibel NL, Dhall G.

Cancer. 2015 Dec 1;121(23):4205-11. doi: 10.1002/cncr.29641. Epub 2015 Aug 26.

30.

Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy.

Blüml S, Margol AS, Sposto R, Kennedy RJ, Robison NJ, Vali M, Hung LT, Muthugounder S, Finlay JL, Erdreich-Epstein A, Gilles FH, Judkins AR, Krieger MD, Dhall G, Nelson MD, Asgharzadeh S.

Neuro Oncol. 2016 Jan;18(1):126-31. doi: 10.1093/neuonc/nov097. Epub 2015 Aug 8.

31.

Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.

Pruitt R, DaSilva NS, Cappellano A, Belessiotis C, Diez B, Gardner S, Allen J, Weinblatt M, Gottardo N, Dhall G, Finlay JL.

Pediatr Blood Cancer. 2015 Nov;62(11):1920-4. doi: 10.1002/pbc.25606. Epub 2015 Jun 5.

PMID:
26054044
32.

Choroid plexus carcinoma in children: the Head Start experience.

Zaky W, Dhall G, Khatua S, Brown RJ, Ginn KF, Gardner SL, Yildiz VO, Yankelevich M, Finlay JL.

Pediatr Blood Cancer. 2015 May;62(5):784-9. doi: 10.1002/pbc.25436. Epub 2015 Feb 8.

PMID:
25662896
33.

Pregnancy in a Patient With a Malignant Brain Tumor Taking Temozolomide: Case Report and Review of the Literature.

Evans AC, Nelson MB, Dhall G.

J Pediatr Oncol Nurs. 2015 Sep-Oct;32(5):326-8. doi: 10.1177/1043454214563414. Epub 2015 Jan 9.

PMID:
25576318
34.

Tumor-associated macrophages in SHH subgroup of medulloblastomas.

Margol AS, Robison NJ, Gnanachandran J, Hung LT, Kennedy RJ, Vali M, Dhall G, Finlay JL, Erdreich-Epstein A, Krieger MD, Drissi R, Fouladi M, Gilles FH, Judkins AR, Sposto R, Asgharzadeh S.

Clin Cancer Res. 2015 Mar 15;21(6):1457-65. doi: 10.1158/1078-0432.CCR-14-1144. Epub 2014 Oct 24.

35.

Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.

Vera-Bolanos E, Aldape K, Yuan Y, Wu J, Wani K, Necesito-Reyes MJ, Colman H, Dhall G, Lieberman FS, Metellus P, Mikkelsen T, Omuro A, Partap S, Prados M, Robins HI, Soffietti R, Wu J, Gilbert MR, Armstrong TS; CERN Foundation.

Neuro Oncol. 2015 Mar;17(3):440-7. doi: 10.1093/neuonc/nou162. Epub 2014 Aug 13.

36.

Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas.

Karajannis MA, Legault G, Fisher MJ, Milla SS, Cohen KJ, Wisoff JH, Harter DH, Goldberg JD, Hochman T, Merkelson A, Bloom MC, Sievert AJ, Resnick AC, Dhall G, Jones DT, Korshunov A, Pfister SM, Eberhart CG, Zagzag D, Allen JC.

Neuro Oncol. 2014 Oct;16(10):1408-16. doi: 10.1093/neuonc/nou059. Epub 2014 May 6.

37.

A retrospective analysis of recurrent intracranial ependymoma.

Antony R, Wong KE, Patel M, Olch AJ, McComb G, Krieger M, Gilles F, Sposto R, Erdreich-Epstein A, Dhall G, Gardner S, Finlay JL.

Pediatr Blood Cancer. 2014 Jul;61(7):1195-201. doi: 10.1002/pbc.24996. Epub 2014 Feb 24.

PMID:
24615997
38.

Treatment of children with diffuse intrinsic pontine gliomas with chemoradiotherapy followed by a combination of temozolomide, irinotecan, and bevacizumab.

Zaky W, Wellner M, Brown RJ, Blüml S, Finlay JL, Dhall G.

Pediatr Hematol Oncol. 2013 Oct;30(7):623-32. doi: 10.3109/08880018.2013.829895.

PMID:
24050762
39.

Infectious complications in the first year following autologous hematopoietic progenitor cell rescue for children with brain tumors.

Brown RJ, Rahim H, Wong KE, Cooper RM, Marachelian A, Butturini A, Dhall G, Finlay JL.

Pediatr Blood Cancer. 2013 Dec;60(12):2012-7. doi: 10.1002/pbc.24665. Epub 2013 Aug 17.

PMID:
23956157
40.

Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.

Zaky W, Dhall G, Ji L, Haley K, Allen J, Atlas M, Bertolone S, Cornelius A, Gardner S, Patel R, Pradhan K, Shen V, Thompson S, Torkildson J, Sposto R, Finlay JL.

Pediatr Blood Cancer. 2014 Jan;61(1):95-101. doi: 10.1002/pbc.24648. Epub 2013 Aug 11.

PMID:
23934933
41.

Feasibility of dasatinib in children and adolescents with new or recurrent central nervous system germinoma.

Osorio DS, Finlay JL, Dhall G, Goldman S, Eisenstat D, Brown RJ.

Pediatr Blood Cancer. 2013 Sep;60(9):E100-2. doi: 10.1002/pbc.24567. Epub 2013 Jun 10.

PMID:
23754592
42.

Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial.

Venkatramani R, Ji L, Lasky J, Haley K, Judkins A, Zhou S, Sposto R, Olshefski R, Garvin J, Tekautz T, Kennedy G, Rassekh SR, Moore T, Gardner S, Allen J, Shore R, Moertel C, Atlas M, Dhall G, Finlay J.

J Neurooncol. 2013 Jun;113(2):285-91. doi: 10.1007/s11060-013-1111-9. Epub 2013 Mar 19.

43.

Chronic myeloid leukemia as a second malignant neoplasm in a patient with medulloblastoma after treatment with chemotherapy and irradiation: a case report and review of the literature.

Dhir N, Zaky W, Zomorodian T, Dhall G.

Pediatr Hematol Oncol. 2013 Feb;30(1):28-9. doi: 10.3109/08880018.2012.748856. Epub 2012 Dec 28. Review. No abstract available.

PMID:
23273112
44.

Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinoma.

Allen J, Chacko J, Donahue B, Dhall G, Kretschmar C, Jakacki R, Holmes E, Pollack I.

Pediatr Blood Cancer. 2012 Dec 15;59(7):1180-2. doi: 10.1002/pbc.24097. Epub 2012 Feb 2.

45.

Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: the Children's Hospital Los Angeles (CHLA) experience, 1991-2010.

Gozali AE, Britt B, Shane L, Gonzalez I, Gilles F, McComb JG, Krieger MD, Lavey RS, Shlien A, Villablanca JG, Erdreich-Epstein A, Dhall G, Jubran R, Tabori U, Malkin D, Finlay JL.

Pediatr Blood Cancer. 2012 Jun;58(6):905-9. doi: 10.1002/pbc.23349. Epub 2011 Oct 11.

PMID:
21990040
46.

Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors.

Dhall D, Mertens R, Bresee C, Parakh R, Wang HL, Li M, Dhall G, Colquhoun SD, Ines D, Chung F, Yu R, Nissen NN, Wolin E.

Hum Pathol. 2012 Apr;43(4):489-95. doi: 10.1016/j.humpath.2011.06.011. Epub 2011 Sep 19.

PMID:
21937080
47.

Elevated citrate in pediatric astrocytomas with malignant progression.

Blüml S, Panigrahy A, Laskov M, Dhall G, Krieger MD, Nelson MD, Finlay JL, Gilles FH.

Neuro Oncol. 2011 Oct;13(10):1107-17. doi: 10.1093/neuonc/nor087. Epub 2011 Jul 19.

48.

Neurocognitive outcomes in pediatric and adolescent patients with central nervous system germinoma treated with a strategy of chemotherapy followed by reduced-dose and volume irradiation.

O'Neil S, Ji L, Buranahirun C, Azoff J, Dhall G, Khatua S, Patel S, Panigrahy A, Borchert M, Sposto R, Finlay J.

Pediatr Blood Cancer. 2011 Oct;57(4):669-73. doi: 10.1002/pbc.23146. Epub 2011 Apr 14.

PMID:
21495164
49.

Supratentorial ependymoma in children: to observe or to treat following gross total resection?

Venkatramani R, Dhall G, Patel M, Grimm J, Hawkins C, McComb G, Krieger M, Wong K, O'Neil S, Finlay JL.

Pediatr Blood Cancer. 2012 Mar;58(3):380-3. doi: 10.1002/pbc.23086. Epub 2011 Mar 2.

PMID:
21370439
50.

The role of chemotherapy in pediatric clival chordomas.

Dhall G, Traverso M, Finlay JL, Shane L, Gonzalez-Gomez I, Jubran R.

J Neurooncol. 2011 Jul;103(3):657-62. doi: 10.1007/s11060-010-0441-0. Epub 2010 Nov 5.

PMID:
21052774

Supplemental Content

Support Center